Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Arch Toxicol. 2019 Jul 10;93(8):2237–2246. doi: 10.1007/s00204-019-02516-4

Fig. 2. Apparent Km of MDA towards recombinant human NAT1 4 and NAT2 4.

Fig. 2

Each bar illustrates the mean ± SEM of MDA apparent KM from three individual determinations carried out at a fixed concentration of 1000 μM AcCoA. MDA exhibited a 6-fold lower (**p < 0.01) apparent KM toward recombinant human NAT2 4 (251 ±80 μM) than recombinant human NAT1 4 (1496 ±213 μM).